Purple Biotech Ltd.
USD1.39
-0.06 (-4.14%)
CEO
Gil Efron
IPO Date
2015-11-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IL
Open
$1.46
Prev. Close
$1.45
Day Low
$1.35
Day High
$1.46
52W Low
$1.35
52W High
$29.00
Market Cap
$0.00B
Volume
0.02M
| $0.00 |
| 7 Apr 2026 | Zilberberg Suzana | director | Disposed | 0 | $0.00 |
| 7 Apr 2026 | Zilberberg Suzana | director | Disposed | 2,650,000 | $0.00 |
| 6 Apr 2026 | Agmon Ido | director | Disposed | 0 | $0.00 |
| 6 Apr 2026 | Agmon Ido | director | Disposed | 2,650,000 | $0.00 |
| 31 Mar 2026 | Efron Gil | Chief Executive Officer | Disposed | 0 | $0.00 |
| 31 Mar 2026 | Efron Gil | Chief Executive Officer | Disposed | 13,500,000 | $0.00 |
| 30 Mar 2026 | Schickler Michael | Head of Clinical & Reg Affairs | Disposed | 0 | $0.00 |
| 30 Mar 2026 | Schickler Michael | Head of Clinical & Reg Affairs | Disposed | 7,100,000 | $0.00 |